Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment

Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment

Abstract Background In the absence of clinical trials, data on the safety of medicine exposures in pregnancy are dependent on observational studies conducted after the agent has been licensed for use. This requires an accurate history of antenatal medicine use to determine potential risks. Medicatio...

Full description

Bibliographic Details
Main Authors: Jani van der Hoven, Elizabeth Allen, Annibale Cois, Renee de Waal, Gary Maartens, Landon Myer, Thokozile Malaba, Hlengiwe Madlala, Dorothy Nyemba, Florence Phelanyane, Andrew Boulle, Ushma Mehta, Emma Kalk
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Pregnancy and Childbirth
Subjects:
Pharmacovigilance
Pregnancy
Antenatal medicine-use
Comparison of data sources
Low- and Middle-income countries
Online Access:https://doi.org/10.1186/s12884-022-04765-1

Internet

https://doi.org/10.1186/s12884-022-04765-1

Similar Items